While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for ...

FDA clears United Therapeutics and eGenesis for gene-edited pig kidney transplant studies, including the first clinical trial ...

Fresh off a reorganization, Biogen’s research leader Jane Grogan says the biotech has to 'look outside the walls of the ...

Phar­ma­ceu­ti­cal in­dus­try groups cau­tion that Pres­i­dent Don­ald Trump’s tar­iffs on Chi­na, Mex­i­co and Cana­da will ...

For the first time, the FDA will consider whether to approve a trio of drugs for tiny patient populations based on trials ...

Noom lays off coaching and customer service staff after slower-than-expected growth in prescription weight loss drug program.

Sen­ate Fi­nance Com­mit­tee De­moc­rats are call­ing Robert F. Kennedy Jr.’s new di­vest­ment plans to his son “plain­ly ...

Charles River Laboratories is permanently closing its pathology facility in Durham, NC, after determining it is no longer “a ...

Pfizer’s Braftovi combo regimen helped prolong the lives of certain patients with previously untreated colorectal cancer, and ...

Radiopharmaceuticals biotech AdvanCell has pulled together a $112 million Series C about two years after its much smaller ...

Thermo Fisher Scientific is cutting 300 employees across two viral vector manufacturing facilities in Massachusetts, marking ...

Cystic fibrosis drug developer Sionna Therapeutics hopes to join the IPO wave started by Metsera and Maze Therapeutics last ...